ArticleFrontiers in immunology2022

Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease.

Kristy E Gilman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.